tm
Seeing Is Believing
tm
Seeing Is Believing
EVAX is currently covered by 2 analysts with an average price target of $15.92. This is a potential upside of $11.81 (287.35%) from yesterday's end of day stock price of $4.11.
Evaxion Biotech AS's activity chart (see below) currently has 4 price targets and 19 ratings on display. The stock rating distribution of EVAX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 38.89% with an average time for these price targets to be met of 235.33 days.
Highest price target for EVAX is $9, Lowest price target is $9, average price target is $9.
Most recent stock forecast was given by THOMAS FLATEN from LAKE STREET on 09-Mar-2026. First documented stock forecast 19-Aug-2021.
Currently out of the existing stock ratings of EVAX, 7 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Mar-2023
$9
$5.22 (138.10%)
$11
1 months 1 days ago
(09-Mar-2026)
2/4 (50%)
$5.92 (192.21%)
422
Buy Since 11-Feb-2024
$16
1 months 1 days ago
(09-Mar-2026)
1/6 (16.67%)
$8.91 (125.67%)
126
Buy Since 19-Aug-2021
$40
$36.09 (923.02%)
$180
2 years 8 days ago
(02-Apr-2024)
1/2 (50%)
$20.6 (106.19%)
158
What is EVAX (Evaxion Biotech AS) average time for price targets to be met?
Which analyst has the current highest performing score on EVAX (Evaxion Biotech AS) with a proven track record?
Which analyst has the current lower performing score on EVAX (Evaxion Biotech AS) with a proven track record?
Which analyst has the most public recommendations on EVAX (Evaxion Biotech AS)?
Which analyst is the currently most bullish on EVAX (Evaxion Biotech AS)?
Which analyst is the currently most reserved on EVAX (Evaxion Biotech AS)?
